Your search history is turned on.
Date: December 22, 2014 Jurisdictions: British Columbia
K & L Gates - Anavex Life Sciences - REVISED Form 51-105F1 (notice of OTC issuer ceasing to be a reporting issuer) (00237368.DOCX;2) {00237368;2} Form 51-105F1 Notice OTC Issuer Ceases to be an OTC Reporting Issuer This is the form required under paragraph 4 (1) (d) of Multilateral Instrument 51-105 Issuers Quoted in the U.S. Over-the...
Date: December 19, 2014 Jurisdictions: British Columbia
Anavex Life Sciences Corp.: Form 424B3 - Filed by newsfilecorp.com Anavex Life Sciences Corp.: Form 424B3 - Filed by newsfilecorp.com http://www.sec.gov/Archives/edgar/data/1314052/000106299314004344/form424b3.htm[12/18/2014 7:49:14 PM] 424B3 1 form424b3.htm FORM 424B3 PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-195225 11,011,420 Shares of Common St...
Anavex Life Sciences Corp.: Form S1 - Filed by newsfilecorp.com http://www.sec.gov/Archives/edgar/data/1314052/000106299314002104/forms1.htm[12/18/2014 7:34:27 PM] S-1 1 forms1.htm FORM S-1 As Filed with the Securities and Exchange Registration No. 333-____________ Commission on April 11, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
Anavex Life Sciences Corp.: Form S-1/A - Filed by newsfilecorp.com http://www.sec.gov/Archives/edgar/data/1314052/000106299314004124/forms1a.htm[12/18/2014 7:42:19 PM] S-1/A 1 forms1a.htm FORM S-1/A As Filed with the Securities and Exchange Commission on July 9, 2014 Registration No. 333-195225 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20...
Anavex Life Sciences Corp. - Form 8-K - Filed by newsfilecorp.com http://www.sec.gov/Archives/edgar/data/1314052/000106299314006111/form8k.htm[12/18/2014 7:55:51 PM] 8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 D...
Anavex Life Sciences Corp.: Form 8K - Filed by newsfilecorp.com http://www.sec.gov/Archives/edgar/data/1314052/000106299314002828/form8k.htm[12/18/2014 7:40:12 PM] 8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date...
Anavex Life Sciences Corp. Form 8-K - Filed by newsfilecorp.com http://www.sec.gov/Archives/edgar/data/1314052/000106299314007087/form8k.htm[12/18/2014 7:59:36 PM] 8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Da...
Anavex Life Sciences Corp.: Form 8-K - Filed by newsfilecorp.com http://www.sec.gov/Archives/edgar/data/1314052/000106299314005194/form8k.htm[12/18/2014 7:50:41 PM] 8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Da...
Date: September 8, 2014 Jurisdictions: British Columbia
Exhibit 31.1 CERTIFICATION I, Christopher Missling, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the three months ended June 30, 2014 of Anavex Life Sciences Corp. (the registrant); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make ...